LONDON, March 23 ― London's FTSE 100 index ended higher yesterday on a weaker pound and as gains in defensive stocks outweighed declines in commodity-linked and travel shares, while drugmaker AstraZeneca jumped on upbeat US trial results.

The FTSE 100 index recouped its early losses and ended 0.3 per cent higher, with dollar-earning consumer staples stocks, including Unilever, Reckitt Benckiser Group, British American Tobacco and Diageo Plc gaining between 0.3 per cent and 2.5 per cent, on the weaker pound.

Healthcare stocks were also among the biggest gainers, with AstraZeneca up 3.3 per cent after the drugmaker's Covid-19 vaccine was found 79 per cent effective in a large US trial at preventing symptomatic illness, and was 100 per cent effective against severe or critical disease and hospitalisation.

Meanwhile, travel and leisure stocks were among the top fallers.

Advertisement

British Airways-owner IAG, down 5.2 per cent, was the biggest faller in the index after social care minister Helen Whately warned that Britons should wait before booking summer holidays abroad, pointing out that there were rising Covid-19 infection rates in Europe.

“The risk, and one being increasingly acknowledged by government ministers, is this summer is even worse than last for the travel space as the UK keeps restrictions in place to avoid undermining its hard-won success with the vaccine,” said Russ Mould, AJ Bell investment director.

The FTSE 100 has rebounded nearly 37 per cent from a coronavirus-driven crash last year on vaccine-led optimism, but has struggled to reach pre-pandemic highs as commodity prices, lockdown measures and rising US bond yields weigh.

Advertisement

Oil heavyweights BP and Royal Dutch Shell also weighed on the index.

The domestically focused mid-cap FTSE 250 index gained 0.2 per cent, supported by tech and bank stocks.

Home improvement retailer Kingfisher rose 3.6 per cent to the top of the blue-chip index, after posting a 44 per cent jump in full-year profit driven by the popularity of do-it-yourself projects during the pandemic. ― Reuters